Abstract

Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
Andrea Pozzi ... Mark C Petrie
European journal of heart failure | VOL. 18
Andrea Pozzi, et. al.Andrea Pozzi ... Mark C Petrie
01 Sep 2016
Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma
Victor Serebruany
EBioMedicine | VOL. 8
Victor SerebruanyVictor Serebruany
27 Apr 2016
Different renal function estimation formulae and implications for dosing and clinical outcomes when prescribing non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
S.A Chen ... C.T Kuo
European Heart Journal | VOL. 41
S.A Chen, et. al.S.A Chen ... C.T Kuo
01 Nov 2020
Stroke and bleed related deaths in newly diagnosed atrial fibrillation patients: insights from the GARFIELD-AF registry
S Virdone ... A K Kakkar
European Heart Journal | VOL. 43
S Virdone, et. al.S Virdone ... A K Kakkar
03 Oct 2022
View more papers

More From: European journal of heart failure

Paper Title
Journal
Date
Author
Sodium-glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure.
Eugenia Cisneros-Barroso ... Xavier Rossello
European journal of heart failure | VOL. -
Eugenia Cisneros-Barroso, et. al.Eugenia Cisneros-Barroso ... Xavier Rossello
29 May 2024
Impact of malnutrition in patients with severe heart failure.
Matteo Pagnesi ... Marco Metra
European journal of heart failure | VOL. -
Matteo Pagnesi, et. al.Matteo Pagnesi ... Marco Metra
29 May 2024
Is the optimal dose of heart failure medical therapy different in women and men?
Maria A Pabon ... Carolyn S P Lam
European journal of heart failure | VOL. -
Maria A Pabon, et. al.Maria A Pabon ... Carolyn S P Lam
27 May 2024
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Lazar Velicki ...
European journal of heart failure | VOL. -
Lazar Velicki, et. al.Lazar Velicki ...
27 May 2024
View more papers